Maplight Therapeutics (MPLT) Form 144: Director plans sale of 3,472 shares via Jefferies

Rhea-AI Filing Summary

Maplight Therapeutics filed a Form 144 notifying an intended sale of 3,472 shares of common stock through Jefferies LLC. The filing also lists a dollar figure of $93,813.44 and 42,440,000 shares outstanding as of 04/15/2026. The excerpt shows recent Restricted Stock Unit Grants of 3,348, 1,545, and 6,350 shares with grant/vesting dates noted.

Insights

Securities Counsel

Form 144 records a planned Rule 144 resale notice by a holder through Jefferies LLC.

The filing lists an intended sale of 3,472 shares with an associated figure of $93,813.44 and cites 42,440,000 shares outstanding as of 04/15/2026. This is a disclosure of a proposed resale under Rule 144, not a market execution confirmation.

Timing and exact sale mechanics are not stated in the excerpt; subsequent trade reports or broker confirmations would show execution details and proceeds realization.

Key Figures

Shares proposed for resale: 3,472 shares Dollar figure shown: $93,813.44 Shares outstanding: 42,440,000 shares +3 more

6 metrics

Shares proposed for resale 3,472 shares listed with Jefferies LLC in the Form 144 excerpt

Dollar figure shown $93,813.44 appears adjacent to the 3,472-share line in the excerpt

Shares outstanding 42,440,000 shares as of <date>04/15/2026</date> shown in the excerpt

RSU grant — 07/30/2023 3,348 shares Restricted Stock Unit Grant with vesting/related date 07/30/2024

RSU grant — 11/09/2023 1,545 shares Restricted Stock Unit Grant dated 11/09/2023

RSU grant — 05/02/2024 6,350 shares Restricted Stock Unit Grant dated 05/02/2024

Key Terms

Restricted Stock Unit Grant, Jefferies LLC, Securities To Be Sold

3 terms

Restricted Stock Unit Grant financial

"Common | 07/30/2023 | Restricted Stock Unit Grant | Maplight"

Jefferies LLC financial

"Common | Jefferies LLC 520 Madison Avenue 4th Floor New York"

Securities To Be Sold regulatory

"144: Securities To Be Sold"

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Jefferies LLC 520 Madison Avenue 4th Floor New York NY 10022	3472	93813.44	42440000	04/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/30/2023	Restricted Stock Unit Grant	Maplight Therapeutics, Inc.			3348	07/30/2024	N/A
Common	11/09/2023	Restricted Stock Unit Grant	Maplight Therapeutics, Inc.			1545	11/09/2023	N/A
Common	05/02/2024	Restricted Stock Unit Grant	Maplight Therapeutics, Inc.			6350	05/02/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Maplight Therapeutics (MPLT) report on Form 144?

The filing notifies an intended resale under Rule 144 of 3,472 shares through Jefferies LLC. It lists a related dollar figure of $93,813.44 and shows 42,440,000 shares outstanding as of 04/15/2026.

Who is handling the proposed sale for MPLT according to the filing?

The proposed sale is listed as to be handled by Jefferies LLC at its New York address. The form cites brokerage placement details but does not include execution timing or final sale confirmation.

Does the Form 144 show any recent equity grants for MPLT insiders?

Yes; the excerpt lists Restricted Stock Unit grants of 3,348, 1,545, and 6,350 shares with associated grant dates and vesting date entries shown in the table fragment.

Does the filing confirm the sale has occurred for MPLT shares?

No; Form 144 provides notice of an intended resale under Rule 144 and does not confirm trade execution or settlement. Execution details would appear in subsequent broker reports or transaction filings.

How many shares outstanding does the excerpt list for MPLT?

The excerpt lists 42,440,000 shares outstanding as of 04/15/2026. This figure appears alongside the sale notice and serves as a context number in the filing fragment.